| Item Type | Name |
|
Concept
|
Immunotherapy, Adoptive
|
|
Academic Article
|
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
|
|
Academic Article
|
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
|
|
Academic Article
|
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.
|
|
Academic Article
|
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
|
|
Academic Article
|
The development of gene therapy for the treatment of cancer.
|
|
Academic Article
|
Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
|
|
Academic Article
|
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma.
|
|
Academic Article
|
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.
|
|
Academic Article
|
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
|
|
Academic Article
|
Antitumor activity of dual-specific T cells and influenza virus.
|
|
Academic Article
|
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.
|
|
Academic Article
|
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
|
|
Academic Article
|
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
|
|
Academic Article
|
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
|
|
Academic Article
|
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
|
|
Academic Article
|
The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
|
|
Academic Article
|
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
|
|
Academic Article
|
Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.
|
|
Academic Article
|
A new approach to simultaneously quantify both TCR a- and ?-chain diversity after adoptive immunotherapy.
|
|
Academic Article
|
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
|
|
Academic Article
|
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
|
|
Academic Article
|
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
|
|
Academic Article
|
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
|
|
Academic Article
|
Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.
|
|
Academic Article
|
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.
|
|
Academic Article
|
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.
|
|
Academic Article
|
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
|
|
Academic Article
|
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
|
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
|
Academic Article
|
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.
|
|
Academic Article
|
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.
|
|
Academic Article
|
T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.
|
|
Academic Article
|
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
|
|
Academic Article
|
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.
|
|
Academic Article
|
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
|
|
Academic Article
|
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
|
|
Academic Article
|
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer.
|
|
Academic Article
|
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling.
|
|
Academic Article
|
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
|
|
Academic Article
|
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
|
|
Academic Article
|
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-? signaling.
|
|
Academic Article
|
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
|